Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Introduction to a review series on von Willebrand factor, factor VIII, and factor IX

Thomas L. Ortel

Blood (2024) 144 (21): 2157–2158.

https://doi.org/10.1182/blood.2024026361

Published: 2024

Journal Articles

The Caprini Score in Black and Latino Patients: A Proposed Race- and Ethnicity-Adjusted Model for Perioperative Venous Thromboembolism Risk Assessment

Ahmad Nassar, Ryan Sun, Danny Hadidi, Margaret E Wright, Subhash K Kolar Rajanna, Sargam Kapoor, Thomas L. Ortel, John G Quigley

Blood (2024) 144 (Supplement 1): 160.

https://doi.org/10.1182/blood-2024-212231

Published: 2024

Journal Articles

Antiphospholipid Syndrome (APS) Is a Platelet Factor 4 (PF4)-Centric Immunothrombotic Disorder

Conroy O Field, Amrita Sarkar, Khalil Bdeir, Keith R. McCrae, Thomas L. Ortel, M. Anna Kowalska, Lubica Rauova, Douglas B. Cines, Kandace Gollomp, Mortimer Poncz

Blood (2024) 144 (Supplement 1): 185.

https://doi.org/10.1182/blood-2024-201682

Published: 2024

Journal Articles

Variants in Complement Regulatory Genes in Patients with Thrombotic Storm

Joseph Zouein, Genesis Soriano, Karen Nuytemans, Lisette Gomez, Patrice Whitehead, Margaret A. Pericak-Vance, Jeffery M. Vance, Thomas L. Ortel

Blood (2024) 144 (Supplement 1): 3997.

https://doi.org/10.1182/blood-2024-208633

Published: 2024

Journal Articles

Anti-Phospholipid Syndrome (APS) Antibody (Ab)-Induced Thrombosis Can be Blocked By Platelet Factor 4 (PF4)-Directed Abs: A Novel Therapeutic Approach for APS?

Amrita Sarkar, Santosh K Yadav, Conroy O Field, Kandace Gollomp, Keith R. McCrae, Thomas L. Ortel, Yves Gruel, Jérôme Rollin, Gowthami M Arepally, Lubica Rauova, Douglas B. Cines, Mortimer Poncz

Blood (2024) 144 (Supplement 1): 2611.

https://doi.org/10.1182/blood-2024-200849

Published: 2024

Journal Articles

The PF4-Centric Immunothrombotic Disorders, HIT, Vitt and APS, Lead to Complement Activation Responsive to Complement-Blocking Therapeutics

Amrita Sarkar, Conroy O Field, Keith R. McCrae, Thomas L. Ortel, Gow Arepally, Roxanne Cofiell, Sung-Kwon Kim, Lubica Rauova, Mortimer Poncz

Blood (2024) 144 (Supplement 1): 2606.

https://doi.org/10.1182/blood-2024-198182

Published: 2024

Journal Articles

Introduction to a review series on factor XI

Thomas L. Ortel

Blood (2024) 143 (15): 1431.

https://doi.org/10.1182/blood.2023020723

Published: 2024

Journal Articles

Introduction to a How I Treat series on hematologic complications in pregnancy

Thomas L. Ortel

Blood (2024) 143 (9): 739–740.

https://doi.org/10.1182/blood.2023020730

Published: 2024

Journal Articles

Introduction to a How I Treat series on geriatric hematology

Thomas L. Ortel

Blood (2024) 143 (3): 185–186.

https://doi.org/10.1182/blood.2023021005

Published: 2024

Journal Articles

Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge from the Hospital Is Not Associated with an Improvement in Quality of Life: Results from the Activ 4c Clinical Trial

Lisa Baumann Kreuziger, Taeim Kwon, Lana Wahid, Raj S. Kasthuri, Andrei L. Kindzelski, M. Margaret Knudson, Jerry Krishnan, Gervasio Lamas, Eric Leifere, Jose Lopez-Sendon, Peter J Miller, Bela Patel, Alexandra J Weissman, John Quigley, Deborah Siegal, Tracy Y Wang, Kevin J Anstrom, Thomas L. Ortel

Blood (2023) 142 (Supplement 1): 2630.

https://doi.org/10.1182/blood-2023-190552

Published: 2023

Journal Articles

Recombinant ADAMTS13 for the Treatment of Acute TTP Events in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Results from the Phase 3 Randomized, Controlled, Crossover Study and the Phase 3b Continuation Study

Marie Scully, Thomas L. Ortel, Ziqiang Yu, Maria Waliullah, Pinghai Zhang, Munjal Patel, Parth Patwari, Bjorn Mellgard, Linda T. Wang

Blood (2023) 142 (Supplement 1): 692.

https://doi.org/10.1182/blood-2023-188996

Published: 2023

Journal Articles

Treatment Complications of Venous Thromboembolism in Patients with Central Nervous System Tumors

Andrew M. Peseski, Thomas L. Ortel, Gloria Broadwater, Claire Bradbury, Margaret O. Johnson

Blood (2023) 142 (Supplement 1): 4028.

https://doi.org/10.1182/blood-2023-188818

Published: 2023

Journal Articles

Introduction to a How I Treat series on consultative hematology for inpatients

Jeanne E. Hendrickson, Thomas L. Ortel

Blood (2023) 142 (9): 751–752.

https://doi.org/10.1182/blood.2023019877

Published: 2023

Journal Articles

Introduction to a review series on pediatric hematology

Thomas L. Ortel, Irene Roberts

Blood (2022) 140 (6): 523.

https://doi.org/10.1182/blood.2022017225

Published: 2022

Journal Articles

Introduction to a review series on COVID-19 and the hematologist

Thomas L. Ortel, Nancy Berliner

Blood (2022) 140 (3): 163–164.

https://doi.org/10.1182/blood.2022017072

Published: 2022

Journal Articles

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know

Gowthami M. Arepally, Thomas L. Ortel

Blood (2021) 138 (4): 293–298.

https://doi.org/10.1182/blood.2021012152

Published: 2021

Journal Articles

Nanoparticle-Directed Targeting of Clustered PSGL-1 Mitigates Neutrophil-Derived Thrombosis in Antiphospholipid Antibody Syndrome

David R Sweet, Asha Thomas, PhD, Stephanie D Lapping, MS, Kenneth A Kalikasingh, Thomas L. Ortel, MD PhD, Mukesh K Jain, MD, Andrei Maiseyeu, Lalitha V. Nayak, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-139543

Published: 2020

Journal Articles

COVID-19 Associated Coagulopathy: Thrombosis, Hemorrhage and Mortality Rates with an Escalated-Thromboprophylaxis Strategy

Molly Daughety, MD, Thomas L. Ortel, MD PhD, Erin Frost, MD, Andrew Morgan, MDPhD, Chester Kao, MD, Joyce Hwang, MD, Bhavik Patel, MD, Ian J Welsby, MBBS

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-142944

Published: 2020

Journal Articles

Introduction to a review series on treatment of venous thrombotic disorders

Thomas L. Ortel

Blood (2020) 135 (5): 299–300.

https://doi.org/10.1182/blood.2019004079

Published: 2020

Journal Articles

Risk Factors Associated with 6-Month Recurrent VTE Among Patients in Two Large Population-Based Surveillance Systems

Alys Adamski, PhD MPH, Aaron Mark Wendelboe, PhD MS, Thomas L. Ortel, MD PhD, Gary E. Raskob, PhD, Nimia Reyes, MD MPH, Ibrahim Saber, MD, Karon Abe, PhD, Michele Beckman, PhD MPH

Blood (2019) 134 (Supplement_1): 3444.

https://doi.org/10.1182/blood-2019-126903

Published: 2019

NARROW

Introduction to a review series on von Willebrand factor, factor VIII, and factor IX

The Caprini Score in Black and Latino Patients: A Proposed Race- and Ethnicity-Adjusted Model for Perioperative Venous Thromboembolism Risk Assessment

Antiphospholipid Syndrome (APS) Is a Platelet Factor 4 (PF4)-Centric Immunothrombotic Disorder

Variants in Complement Regulatory Genes in Patients with Thrombotic Storm

Anti-Phospholipid Syndrome (APS) Antibody (Ab)-Induced Thrombosis Can be Blocked By Platelet Factor 4 (PF4)-Directed Abs: A Novel Therapeutic Approach for APS?

The PF4-Centric Immunothrombotic Disorders, HIT, Vitt and APS, Lead to Complement Activation Responsive to Complement-Blocking Therapeutics

Introduction to a review series on factor XI

Introduction to a How I Treat series on hematologic complications in pregnancy

Introduction to a How I Treat series on geriatric hematology

Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge from the Hospital Is Not Associated with an Improvement in Quality of Life: Results from the Activ 4c Clinical Trial

Recombinant ADAMTS13 for the Treatment of Acute TTP Events in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Results from the Phase 3 Randomized, Controlled, Crossover Study and the Phase 3b Continuation Study

Treatment Complications of Venous Thromboembolism in Patients with Central Nervous System Tumors

Introduction to a How I Treat series on consultative hematology for inpatients

Introduction to a review series on pediatric hematology

Introduction to a review series on COVID-19 and the hematologist

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know

Nanoparticle-Directed Targeting of Clustered PSGL-1 Mitigates Neutrophil-Derived Thrombosis in Antiphospholipid Antibody Syndrome

COVID-19 Associated Coagulopathy: Thrombosis, Hemorrhage and Mortality Rates with an Escalated-Thromboprophylaxis Strategy

Introduction to a review series on treatment of venous thrombotic disorders

Risk Factors Associated with 6-Month Recurrent VTE Among Patients in Two Large Population-Based Surveillance Systems

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only